The Efficacy and Tolerability of Milnacipran 100 mg/day Monotherapy for the Management of Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
Arnold, Lesley M.
Gendreau, R. Michael
Spera, Allan
Gendreau, Judy
Wang, Yong
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A187 / A187
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double-blind, placebo-controlled trial
    Xiang, Yingying
    Shen, Lixuan
    Xue, Yingying
    Wang, Ziwei
    Zhou, Ruonan
    Cao, Yue
    Zhu, Ziwei
    Xu, Pingyuan
    Yu, Xizhong
    Fang, Penghua
    Shang, Wenbin
    [J]. DIABETES OBESITY & METABOLISM, 2024,
  • [22] Efficacy and tolerability of pregabalin in essential tremor: A randomized, double-blind, placebo-controlled, crossover trial
    Ferrara, Joseph M.
    Kenney, Christopher
    Davidson, Anthony L.
    Shinawi, Lina
    Kissel, Abigail M.
    Jankovic, Joseph
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 (1-2) : 195 - 197
  • [23] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUOXETINE IN FIBROMYALGIA
    WOLFE, F
    CATHEY, MA
    HAWLEY, DJ
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (05) : 255 - 259
  • [24] Efficacy, Tolerability, and Immunogenicity of OnabotulinumtoxinA in a Randomized, Double-Blind, Placebo-Controlled Trial for Cervical Dystonia
    Charles, David
    Brashear, Allison
    Hauser, Robert A.
    Li, Hung-Ir
    Boo, Lee-Ming
    Brin, Mitchell F.
    [J]. CLINICAL NEUROPHARMACOLOGY, 2012, 35 (05) : 208 - 214
  • [25] Dual Reuptake Inhibitor Milnacipran and Spinal Pain Pathways in Fibromyalgia Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
    Matthey, Alain
    Cedraschi, Christine
    Piguet, Valerie
    Besson, Marie
    Chabert, Jocelyne
    Daali, Youssef
    Courvoisier, Delphine
    Montagne, Agnes
    Dayer, Pierre
    Desmeules, Jules
    [J]. PAIN PHYSICIAN, 2013, 16 (05) : E553 - E562
  • [26] Worsening of Fibromyalgia Symptoms Following Abrupt Discontinuation of Milnacipran: Results from a Randomized, Double-Blind, Placebo-Controlled Trial
    Saxe, Philippe A.
    Arnold, Lesley M.
    Gendreau, R. Michael
    Spera, Allan
    Gendreau, Judy
    Wang, Yong
    [J]. NEUROLOGY, 2010, 74 (09) : A187 - A187
  • [27] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Switch Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Patients with An Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
    Bateman, Lucinda
    Spera, Allan
    Palmer, Robert H.
    Trugman, Joel M.
    Lin, Jennifer
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S628 - S628
  • [28] Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial
    Arnold, Lesley M.
    Goldenberg, Don L.
    Stanford, Sharon B.
    Lalonde, Justine K.
    Sandhu, H. S.
    Keck, Paul E., Jr.
    Welge, Jeffrey A.
    Bishop, Fred
    Stanford, Kevin E.
    Hess, Evelyn V.
    Hudson, James I.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1336 - 1344
  • [29] Venlafaxine in fibromyalgia: Results of a randomized, placebo-controlled, double-blind trial.
    Zijlstra, TR
    Barendregt, PJ
    van De Laar, MAF
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S105 - S105
  • [30] An International, Randomized, Double-blind, Placebo-controlled, Phase III Trial of Pregabalin Monotherapy in Treatment of Patients with Fibromyalgia
    Pauer, Lynne
    Winkelmann, Andreas
    Arsenault, Pierre
    Jespersen, Anders
    Whelan, Laurence
    Atkinson, Gary
    Leon, Teresa
    Zeiher, Bernhardt
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (12) : 2643 - 2652
12345